Fixed income market outlook: why short-term bonds may outperform in 2H 2025
ADVERTISEMENT According to the Fixed Income Market Outlook (July 2025) report by Axis Mutual Fund, abundant liquidity, falling inflation, and a shallow rate cut cycle are shaping a nuanced bond market strategy for the months ahead.Recent geopolitical tensions between Israel and Iran have driven global investors towards safer assets like bonds and gold. In the US, 10-year Treasury yields slipped by 17 basis points to 4.23%. Meanwhile, Indian 10-year government bond yields inched up by 3 basis points to settle at 6.32%, largely due to abundant banking liquidity and moderating inflation trends.
The Reserve Bank of India (RBI) conducted a ₹84,975 crore VRRR (Variable Rate Reverse Repo) auction to manage excess liquidity. Overnight rates are currently trading below the Standing Deposit Facility (SDF), prompting the central bank to maintain short-term policy interventions. India's headline inflation fell to 2.8% in May 2025, thanks to easing food prices and an expected above-normal monsoon. Analysts expect inflation to stay around or below 3% in the near term. Industrial production slowed to 1.2% in May, with the mining and electricity sectors dragging overall growth. However, India posted a robust current account surplus of 1.3% of GDP in Q4FY25—the strongest in over 15 years—driven by resilient service exports and front-loaded goods shipments ahead of US tariffs.
ADVERTISEMENT
The rupee remained broadly stable against the US dollar, as the greenback weakened against most major currencies.
While bond markets have benefited from a strong rally over the past 12 months, analysts now expect the upside to be limited, particularly for long-duration government bonds. With much of the rate-cut-driven rally already priced in (10-year yields have already fallen by 70–75 bps over the last year), experts predict that yields will likely remain range-bound between 6% and 6.40% for 10-year G-Secs in the coming months.
ADVERTISEMENT
The report emphasizes a clear tactical shift towards short-duration bonds. Several factors support this view: Surplus system liquidity and subdued credit growth favor short-end corporate bonds.
A shallow rate cut cycle and limited OMO (Open Market Operations) purchases further restrict long-duration bond rallies.
Corporate bonds with maturities of 1 to 5 years are expected to outperform long bonds from a risk-reward standpoint.
AAA-rated corporate bonds maturing within 3 to 10 years are likely to offer yields between 6.50% and 6.75%, providing incremental gains of 50–100 basis points.
Globally, while tariff uncertainties between the US and its trading partners are easing, negotiations remain ongoing. The US Federal Reserve is expected to resume its rate-cutting cycle soon, with two cuts likely in 2025 as growth slows and labor market data weakens. However, the Fed's cautious approach keeps markets volatile.
ADVERTISEMENT
Given the current environment, investment experts recommend: Maintaining allocations to short- to medium-term bond funds.
Gradually adding duration during yield spikes.
Favoring government securities (G-Secs) in long-term portfolios while increasing exposure to 1–5-year corporate bonds for better near-term returns.
With the bulk of the bond rally behind us, the report advises investors to focus on short-term corporate bond funds and tactical gilt funds. Selective credits also remain attractive due to improving macro fundamentals and corporate profitability.
ADVERTISEMENT In short, the fixed-income space continues to offer opportunities—but disciplined portfolio allocation, duration management, and selective sector exposure will be critical for capturing returns in 2H 2025.
(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)
(You can now subscribe to our ETMarkets WhatsApp channel)
bond marketinflationaxis mutual fundcorporate bondsyieldsstrategy Nikita Papers IPO opens on May 27, price band set at Rs 95-104 per share
Nikita Papers IPO opens on May 27, price band set at Rs 95-104 per share Why gold prices could surpass $4,000: JP Morgan's bullish outlook explained
Why gold prices could surpass $4,000: JP Morgan's bullish outlook explained Cyient shares fall over 9% after Q4 profit declines, core business underperforms
Cyient shares fall over 9% after Q4 profit declines, core business underperforms L&T Technology Services shares slide 7% after Q4 profit dips
L&T Technology Services shares slide 7% after Q4 profit dips Trump-Powell standoff puts U.S. Rate policy in crosshairs: Who will blink first?
Trump-Powell standoff puts U.S. Rate policy in crosshairs: Who will blink first? SEBI warns of securities market frauds via YouTube, Facebook, X and more
SEBI warns of securities market frauds via YouTube, Facebook, X and more API Trading for All: Pi42 CTO Satish Mishra on How Pi42 is Empowering Retail Traders
API Trading for All: Pi42 CTO Satish Mishra on How Pi42 is Empowering Retail Traders Security, transparency, and innovation: What sets Pi42 apart in crypto trading
Security, transparency, and innovation: What sets Pi42 apart in crypto trading Bitcoin, Ethereum, or Altcoins? How investors are structuring their crypto portfolios, Avinash Shekhar explains
Bitcoin, Ethereum, or Altcoins? How investors are structuring their crypto portfolios, Avinash Shekhar explains The rise of Crypto Futures in India: Leverage, tax efficiency, and market maturity, Avinash Shekhar of Pi42 explains
NEXT STORY
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
12 minutes ago
- Mint
Anthem Biosciences IPO listing date today. GMP, analysts signal strong debut of shares in stock market today
Anthem Biosciences IPO Listing: Anthem Biosciences shares are set to make their debut in the Indian stock market today. The initial public offering (IPO) of specialized fermentation-based APIs manufacturer received stellar demand during its subscription period, and Anthem Biosciences IPO listing date is today. The public issue was open from July 14 to July 16, and Anthem Biosciences IPO allotment date was July 17. Anthem Biosciences IPO listing date is today, 21 July 2025. Anthem Biosciences shares will be listed today on both the stock exchanges, BSE and NSE. 'Trading Members of the Exchange are hereby informed that effective from Monday, July 21, 2025, the equity shares of Anthem Biosciences Limited shall be listed and admitted to dealings on the Exchange in the list of 'B' Group of Securities,' a notice on the BSE said. Anthem Biosciences shares will be a part of Special Pre-open Session (SPOS) on Monday, July 21, 2025, it added, and the stock will be available for trading from 10:00 AM. Ahead of Anthem Biosciences IPO listing today, investors watch out for the trends in grey market premium (GMP) in order to gauge the estimated listing price of the shares. Anthem Biosciences IPO GMP today and analysts signal a strong debut of shares in the Indian stock market today. Here's what Anthem Biosciences IPO GMP indicates: The trends for Anthem Biosciences shares in the unlisted market remains bullish with a strong grey market premium. According to stock market experts, Anthem Biosciences IPO GMP today is ₹ 177 per share. This indicates that Anthem Biosciences shares are available at a premium of ₹ 177 apiece in the grey market than their issue price of ₹ 570 per share. Anthem Biosciences IPO GMP today signals that the estimated Anthem Biosciences share listing price would be ₹ 747 apiece, which is at a 31.05% premium to the IPO price of ₹ 570 per share. Analysts also expect Anthem Biosciences shares to list at a strong premium to its issue price on the stock exchanges. 'Anthem Biosciences is expected to make a strong debut on the stock exchanges. Given the robust investor demand during the IPO particularly from institutional investors, the shares suggest a potential listing in the range of ₹ 700 or higher, translating into a premium of around 20–25%,' said Mahesh M. Ojha, AVP - Research & Business Development, Hensex Securities Pvt. Ltd.. According to him, from a fundamentals perspective, a premium listing appears reasonable. Harshal Dasani Business Head, INVasset PMS, noted that over the weekend, Anthem Biosciences IPO GMP rose further to ₹ 165–170, indicating a likely listing price of ₹ 735–740, or a listing gain of approximately 29%. 'This level of interest reflects extraordinary investor conviction and places Anthem in an elite bracket of biotech listings in India. With no fresh issue component, there is zero dilution and no pressure to deploy new capital. If Q2 earnings keep pace and listing trends match market buzz, Anthem Biosciences could well position itself as the poster child of India's biotech resurgence,' said Dasani. The bidding for the Anthem Biosciences IPO opened on Monday, July 14, and closed on Wednesday, July 16. The IPO allotment date was July 17, and the Anthem Biosciences IPO listing date is today, 21 July 2025. Anthem Biosciences shares will be listed on BSE and NSE. The ₹ 3,395.00-crore Anthem Biosciences IPO was entirely an offer-for-sale (OFS) of 5.96 crore equity shares, issued at a fixed IPO price band of ₹ 570 per share. Anthem Biosciences IPO was subscribed 63.86 times in total, as per the NSE subscription data. The retail portion was booked 5.64 times, while the Non Institutional Investors (NII) segment was subscribed 42.36 times. The Qualified Institutional Buyers (QIBs) category received 182.65 times subscription. JM Financial is the book-running lead manager of the Anthem Biosciences IPO, while Kfin Technologies is the registrar for the issue. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Scroll.in
12 minutes ago
- Scroll.in
China's export restrictions on rare earth minerals could work to India's advantage
Around 80 years ago, in an assertive move, India had imposed restrictions on the export of rare earth-rich monazite sands to the US. As one of the largest global producers of rare earth minerals at the time, New Delhi's actions caused consternation in Washington given the importance of these minerals to the US's atomic energy ambitions. The objective of the export controls by the newly independent Indian government was to build a domestic processing industry and support the country's industrial ambitions. Despite the initial disruption, this action eventually expedited efforts by the US to look for domestic sources of rare earths which led to the finding of the massive Mountain Pass mine in Nevada and, subsequently, the buildout of the US rare earths industry. This slice of history has several lessons for Indian – and US – policymakers as they seek to deal with China's restrictions on the export of seven medium and heavy rare earths and magnets, which is expected to severely disrupt the production lines of automakers, renewable energy developers and the defence industry. Supplies from China have resumed to some US and European Union companies following diplomatic negotiations, but Indian companies appear to have had no such luck. Maruti Suzuki, India's largest automaker, is planning to reduce production of its flagship electric sports utility vehicle, e-Vitara. Several renewable energy developers are considering invoking force majeure clauses, seeking exemption from their obligations. This also highlights the risk of disruptions to solar panel and wind turbine manufacturing and underlines the importance of rare earth magnets for a variety of high-tech industries and industrial uses. Even though India has the third-largest global reserves of rare earths, the country is highly dependent on imports of these minerals and magnets. In the fiscal year 2024-'25, India imported 53,748 metric tonnes of rare earth magnets and 2,270 tonnes of rare earth metals and compounds in 2023-'24, mainly from China. The main reason for this import dependence is the inability to build deep expertise in the processing and magnet-making segments of the rare earths supply chain. Furthermore, the monazite reserves in India are typically found along with thorium, a radioactive material which makes it more costly and technically complex to process. In contrast, the US and China have bastnaesite reserves, which have lower radiation levels. The Indian government has launched some promising steps to address this challenge such as expediting auctions for the domestic exploration of critical minerals, including rare earths. It is also reportedly in the process of launching a production-linked incentive scheme to encourage companies to expand the domestic processing of rare earths and magnet production. Given the scale of the challenge, it will be crucial for India to come up with a multi-pronged strategy. Here are some steps India could take in the short, medium and long-term. Diplomacy, trade deals It will be crucial for the government to engage diplomatically with China to facilitate a temporary easing of rare earth and magnet supplies for Indian companies, similar to steps undertaken by the US and European Union. India lacks the same economic leverage so some concessions will likely need to be made to facilitate imports. At the same time, the government can temporarily dilute localisation regulations so that domestic companies can undertake the sub-assembly of rare earth motors in China and import them to India. These don't appear to be subjected to export controls by the Chinese government. In parallel, India should pursue offtake agreements with international rare earth suppliers, such as Myanmar, Australia and Vietnam and build technological partnerships with countries that have built up expertise in heavy rare earths separation, such as in Japan and Malaysia. Offtake agreements are commitments to purchase a specified quantity of minerals in the future and help mining companies reduce the risk of investing given the long timeframe from exploration to production. Indian Rare Earths Limited, a state-owned company, is in the process of producing magnets from rare earths found within India, and could collaborate with international companies to further upgrade its technologies. Partnerships to build domestic capacity It will be crucial to incentivise the use of rare earth-free motors by domestic companies to derisk from China. There are several examples of international automakers, such as Nissan and Renault, building rare-earth free motors following the temporary restrictions of rare earths to Japan from China in 2010. The use of these motors however fizzled away after exports from China resumed. India could facilitate partnerships between domestic companies with Japanese and Taiwanese companies to licence these technologies and promote their use by domestic automakers through incentives and mandates. The qualification timelines for these motors are likely to be 12-18 months so it will be crucial to provide regulatory certainty to maintain their adoption even if the current restrictions are relaxed by China. India should also stockpile rare earth ores and metals for its defence industry through strategic public investments. Rare earths run the risk of oxidation, so stockpiles need to be carefully managed and mainly used for strategic purposes. Reforms, research India should also seek to accelerate the domestic exploration of rare earths through regulatory reforms. Although these reforms will need to be implemented soon, the long timelines associated with the mining industry mean that these mines will likely take several years before starting production. It is crucial to recognise that rare earths aren't the only elements where India has a strategic vulnerability. China's concentration in the processing of graphite is equally significant, and export restrictions on graphite-derived technologies, such as anodes used in EV batteries, is another strategic vulnerability. This is an area where India could have a comparative advantage by expanding synthetic graphite production, which is already being undertaken to some extent by domestic companies. Aside from building technical know-how and providing generous subsidies, China's success is also a result of outlining a clear vision in moving towards a low-carbon economy, which provides offtake certainty to mining and processing companies. Green technologies are anticipated to become the largest demand source of many critical minerals in the future, so accelerating domestic clean energy manufacturing ensures supply certainty for mining and processing companies. India can commit more fully towards clean energy technologies through regulatory frameworks, incentives and international collaborations, which can build economies of scale. China's rare earth restrictions should serve as a wake-up call for India to act decisively to secure its interests, as it did so in the past. Those who forget their history often fail to learn from it.
Time of India
42 minutes ago
- Time of India
AI-assisted coding is the way to go when hiring graduates: LTIMindtree CEO
Academy Empower your mind, elevate your skills Hiring for freshers or entry-level graduates will have artificial intelligence or AI-assisted coding as part of the improvised assessment as the correlation between revenue and headcount growth becomes more de-linear, said chief executive officer (CEO) of the sixth-largest Indian IT company, LTIMindtree 'We are very optimistic about continuing our effort in inducting freshers. We added 1,600 freshers this quarter and we are going to add more throughout this year as well. AI-assisted coding is the way to go about it,' said Venugopal Lambu Lambu said there was more emphasis in terms of the learning ability, and the foundational skill sets that freshers have on which companies can build, using their training and learning methods.'So those assessments will always improvise it…Whenever we hire people, we take all those aspects, whether it is related to the coding roles, cloud roles or infrastructure roles or data roles,' he on freshers by building a pyramid-style organisation structure has been key for the over-$283-billion outsourcing industry's services delivery model. However, over the past more than a year, since AI took centre-stage entry-level jobs and hiring at technology firms was impacted with companies coding 20-25% via AI, reducing the need for junior-level human AI technology permeates across functions and solutions, Lambu believes there is a correlation or a non-linearity in the revenue growth and workforce addition.'Over the last few quarters, when we added revenue, the headcount has not necessarily increased. So, there is a correlation or a non-linearity, but it is too early to call out to what extent it will happen,' he added. LTIMindtree , formed with the merger of L&T Infotech and Mindtree in November 2022, last week reported a 5.2% year-on-year growth in the first quarter revenue of fiscal year 2026 at $1.15 billion. It was a 1.97% sequential rise boosted by healthy growth from Europe and its consumer or retail transitioned to take over the Mumbai-headquartered Larsen & Toubro (L&T) subsidiary's top seat on May 31, after induction into the firm in company announced its largest deal with a US-based client worth $450 million in the first quarter.'We are on the verge of signing a couple of deals, and one of them will actually beat our own record. That gives me the confidence that we will move towards the double-digit growth at some time in the second half of the year,' Lambu IT industry has been struggling with low single-digit to flat business growth over the past two years after more than two decades of strong double-digit revenue growth tariff-led macro uncertainties and the AI-backed efficiencies increase cost pressures, most software service providers are witnessing a demand contraction from top clients. This is lowering revenue contribution from large deals, a key vector for IT firms' growth.'Our contribution of top clients' revenue decreased because it has moved to the other categories. For example, we added two new $50 million-plus accounts on-year basis…The portfolio mix also is changing as we start building larger deals,' Lambu we are betting big on AI, Lambu said, AI will be net positive for both revenue and margin growth, which it expects to be closer to 16% in the next couple of quarters from 14.3% in the June quarter.
